Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 6
1976 10
1977 8
1978 5
1979 6
1980 7
1981 10
1982 5
1983 6
1984 10
1985 15
1986 14
1987 21
1988 24
1989 25
1990 22
1991 17
1992 25
1993 14
1994 29
1995 25
1996 22
1997 22
1998 20
1999 10
2000 24
2001 23
2002 21
2003 23
2004 27
2005 22
2006 17
2007 21
2008 25
2009 22
2010 17
2011 23
2012 23
2013 17
2014 23
2015 20
2016 17
2017 14
2018 16
2019 18
2020 8
2021 10
2022 5
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

763 results

Results by year

Filters applied: . Clear all
Page 1
Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia.
Bejanyan N, Kim S, Hebert KM, Kekre N, Abdel-Azim H, Ahmed I, Aljurf M, Badawy SM, Beitinjaneh A, Boelens JJ, Diaz MA, Dvorak CC, Gadalla S, Gajewski J, Gale RP, Ganguly S, Gennery AR, George B, Gergis U, Gómez-Almaguer D, Vicent MG, Hashem H, Kamble RT, Kasow KA, Lazarus HM, Mathews V, Orchard PJ, Pulsipher M, Ringden O, Schultz K, Teira P, Woolfrey AE, Saldaña BD, Savani B, Winiarski J, Yared J, Weisdorf DJ, Antin JH, Eapen M. Bejanyan N, et al. Among authors: ringden o. Blood Adv. 2019 Oct 22;3(20):3123-3131. doi: 10.1182/bloodadvances.2019000722. Blood Adv. 2019. PMID: 31648332 Free PMC article.
In memoriam--Carl-Gustav Groth 1933-2014.
Ericzon BG, Lundgren G, Tibell A, Tydén G, Ringdén O. Ericzon BG, et al. Among authors: ringden o. Transplantation. 2014 Jul 27;98(2):122-3. doi: 10.1097/TP.0000000000000259. Transplantation. 2014. PMID: 24926833 No abstract available.
Busulfan bioavailability.
Hassan M, Ljungman P, Bolme P, Ringdén O, Syrůcková Z, Békàssy A, Starý J, Wallin I, Kållberg N. Hassan M, et al. Among authors: ringden o. Blood. 1994 Oct 1;84(7):2144-50. Blood. 1994. PMID: 7919328 Free article.
Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis.
Saliba RM, Alousi AM, Pidala J, Arora M, Spellman SR, Hemmer MT, Wang T, Abboud C, Ahmed S, Antin JH, Beitinjaneh A, Buchbinder D, Byrne M, Cahn JY, Choe H, Hanna R, Hematti P, Kamble RT, Kitko CL, Laughlin M, Lekakis L, MacMillan ML, Martino R, Mehta PA, Nishihori T, Patel SS, Perales MA, Rangarajan HG, Ringdén O, Rosenthal J, Savani BN, Schultz KR, Seo S, Teshima T, van der Poel M, Verdonck LF, Weisdorf D, Wirk B, Yared JA, Schriber J, Champlin RE, Ciurea SO. Saliba RM, et al. Among authors: ringden o. Transplant Cell Ther. 2022 Oct;28(10):681-693. doi: 10.1016/j.jtct.2022.07.013. Epub 2022 Jul 16. Transplant Cell Ther. 2022. PMID: 35853610 Free PMC article.
Stromal cells-are they really useful for GVHD?
Kaipe H, Erkers T, Sadeghi B, Ringdén O. Kaipe H, et al. Among authors: ringden o. Bone Marrow Transplant. 2014 Jun;49(6):737-43. doi: 10.1038/bmt.2013.237. Epub 2014 Jan 27. Bone Marrow Transplant. 2014. PMID: 24464141 Review.
The allogeneic graft-versus-cancer effect.
Ringdén O, Karlsson H, Olsson R, Omazic B, Uhlin M. Ringdén O, et al. Br J Haematol. 2009 Dec;147(5):614-33. doi: 10.1111/j.1365-2141.2009.07886.x. Epub 2009 Sep 4. Br J Haematol. 2009. PMID: 19735262 Free article. Review.
Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia.
Wieduwilt MJ, Metheny L, Zhang MJ, Wang HL, Estrada-Merly N, Marks DI, Al-Homsi AS, Muffly L, Chao N, Rizzieri D, Gale RP, Gadalla SM, Cairo M, Mussetti A, Gore S, Bhatt VR, Patel SS, Michelis FV, Inamoto Y, Badawy SM, Copelan E, Palmisiano N, Kharfan-Dabaja MA, Lazarus HM, Ganguly S, Bredeson C, Diaz Perez MA, Cassaday R, Savani BN, Ballen K, Martino R, Wirk B, Bacher U, Aljurf M, Bashey A, Murthy HS, Yared JA, Aldoss I, Farhadfar N, Liu H, Abdel-Azim H, Waller EK, Solh M, Seftel MD, van der Poel M, Grunwald MR, Liesveld JL, Kamble RT, McGuirk J, Munker R, Cahn JY, Lee JW, Freytes CO, Krem MM, Winestone LE, Gergis U, Nathan S, Olsson RF, Verdonck LF, Sharma A, Ringdén O, Friend BD, Cerny J, Choe H, Chhabra S, Nishihori T, Seo S, George B, Baxter-Lowe LA, Hildebrandt GC, de Lima M, Litzow M, Kebriaei P, Hourigan CS, Abid MB, Weisdorf DJ, Saber W. Wieduwilt MJ, et al. Among authors: ringden o. Blood Adv. 2022 Jan 11;6(1):339-357. doi: 10.1182/bloodadvances.2021004916. Blood Adv. 2022. PMID: 34547770 Free PMC article.
763 results